Analysts Issue Forecasts for Appili Therapeutics Inc.'s FY2023 Earnings (TSE:APL)
Analysts Issue Forecasts for Appili Therapeutics Inc.'s FY2023 Earnings (TSE:APL)
Appili Therapeutics Inc. (TSE:APL – Get Rating) – Stock analysts at Zacks Small Cap issued their FY2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a report released on Thursday, July 14th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings of ($0.10) per share for the year. Zacks Small Cap also issued estimates for Appili Therapeutics' FY2024 earnings at ($0.07) EPS and FY2025 earnings at ($0.06) EPS.
Appili治疗公司(多伦多证券交易所股票代码：APL-GET评级)--Zack Small Cap的股票分析师在7月14日星期四发布的一份报告中发布了他们对Appili治疗公司股票2023财年每股收益(EPS)的估计。Zack Small Cap分析师D·鲍茨预计，该公司今年的每股收益将达到0.10美元。扎克斯小盘股还发布了对Appili Treateutics 2024财年每股收益(0.07美元)和2025财年每股收益(0.06美元)的估计。
Appili Therapeutics Price Performance
阿普利治疗公司性价比
Read More
阅读更多内容
- Is it Time to Cash Out Novavax Stock?
- Should you buy Bank of America Stock After Its Q2 Earnings Report?
- Monthly Dividend Stocks Can Provide Solid Income
- AMC Entertainment Is On Track For Blockbuster Results
- Why Did State Street's Stock Rally Despite Weaker Earnings?
- 是时候套现Novavax股票了吗？
- 在美国银行第二季度收益报告公布后，你应该买入它的股票吗？
- 每月分红股票可以提供稳定的收入
- AMC娱乐公司有望获得百视达业绩
- 为什么道富银行的股票在盈利疲软的情况下仍出现反弹？
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
获得《阿普利治疗日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Appili Treateutics和相关公司的最新新闻和分析师评级的每日简要摘要。